Gastroesophageal Reflux Disease and Obesity: Not as Simple as We May Think

Richter, Joel
July 2012
Digestive Diseases & Sciences;Jul2012, Vol. 57 Issue 7, p1748
Academic Journal
No abstract available.


Related Articles

  • Comments on a Prospective Study into Using Prokinetics with Proton Pump Inhibitors. Langstaff, Lorna // Journal of Otolaryngology -- Head & Neck Surgery;Apr2012, Vol. 41 Issue 2, p152 

    A letter to the editor is presented in response to the article "Virtue of Adding Prokinetics to Proton Pump Inhibitors in the Treatment of Laryngopharyngeal Reflux Disease: Prospective Study" by W. F. Ezzat et al.

  • A Prospective Study to Compare a Symptom-Based Reflux Disease Questionnaire to 48-h Wireless pH Monitoring for the Identification of Gastroesophageal Reflux (revised 2-26-11). Lacy, Brian E.; Chehade, Robert; Crowell, Michael D. // American Journal of Gastroenterology;Sep2011, Vol. 106 Issue 9, p1604 

    OBJECTIVES:The gastroesophageal reflux disease questionnaire (GerdQ) is a validated questionnaire that identifies patients with gastroesophageal reflux disease (GERD). The aim of this study was to prospectively evaluate the association between GerdQ scores and 48-h wireless pH recording in...

  • Long-term treatment with proton pump inhibitor is associated with undesired weight gain. Yoshikawa, Ichiro; Nagato, Makiko; Yamasaki, Masahiro; Kume, Keiichiro; Otsuki, Makoto; Lijima, Katsunori; Ukleja, Andrew // World Journal of Gastroenterology;10/14/2009, Vol. 15 Issue 38, p4794 

    AIM: To examine the effects of long-term proton pump inhibitor (PPI) therapy on body weight (BW) and body mass index (BMI) in patients with gastroesophageal reflux disease (GERD). METHODS: The subjects were 52 patients with GERD and 58 sex- and age-matched healthy controls. GERD patients were...

  • Control of Acid and Duodenogastroesophageal Reflux (DGER) in Patients With Barrett's Esophagus. Yachimski, Patrick; Maqbool, Sabba; Bhat, Yasser M; Richter, Joel E; Falk, Gary W; Vaezi, Michael F // American Journal of Gastroenterology;Aug2015, Vol. 110 Issue 8, p1143 

    OBJECTIVES:Symptom eradication in patients with Barrett's esophagus (BE) does not guarantee control of acid or duodenogastroesophageal reflux (DGER). Continued reflux of acid and/or DGER may increase risk of neoplastic progression and may decrease the likelihood of columnar mucosa eradication...

  • Body Mass Index and the Efficacy of Acid-Mediating Agents for GERD. Brian Jacobson // Digestive Diseases & Sciences;Sep2008, Vol. 53 Issue 9, p2313 

    Abstract  In studies of the association between obesity and gastroesophageal reflux, one subject that has received very little attention is the effect excess body mass may have on the effectiveness of acid-mediating agents. The lack of systematic research may reflect the perceived high...

  • Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole. Heading, Robert C.; Mönnikes, Hubert; Tholen, Anne; Schmitt, Holger // BMC Gastroenterology;2011, Vol. 11 Issue 1, p52 

    Background: Management of patients with gastro-oesophageal reflux disease (GORD) can be assisted by information predicting the likely response to proton pump inhibitor (PPI) treatment. The aim was to undertake a study of GORD patients designed to approximate ordinary clinical practice that would...

  • Do proton pump inhibitors protect against cancer progression in GERD? Miyashita, Tomoharu; Shah, Furhawn; Harmon, John; Marti, Guy; Matsui, Daisuke; Okamoto, Koichi; Makino, Isamu; Hayashi, Hironori; Oyama, Katsunobu; Nakagawara, Hisatoshi; Tajima, Hidehiro; Fujita, Hideto; Takamura, Hiroyuki; Murakami, Manabu; Ninomiya, Itasu; Kitagawa, Hirohisa; Fushida, Sachio; Fujimura, Takashi; Ohta, Tetsuo // Surgery Today;Aug2013, Vol. 43 Issue 8, p831 

    Gastro-duodenal content reflux from gastro-esophageal reflux disease (GERD) induces the inflammation-metaplasia-dysplasia-adenocarcinoma sequence. Proton pump inhibitors (PPIs) are potent blockers of gastric acid secretion, which are widely used for treating GERD and peptic ulcer-associated...

  • Gastroesophageal reflux disease. Are we acting in the best interest of our patients? TEBALA, G. D. // European Review for Medical & Pharmacological Sciences;Nov2016, Vol. 20 Issue 21, p4553 

    Oesophageal adenocarcinoma is strictly related to gastroesophageal reflux and cylindrical metaplasia of the epithelium of the distal esophagus (Barrett's esophagus) due to chronic inflammation. Worldwide incidence of oesophageal adenocarcinoma is rising despite the availability of precise...

  • Block The Deadly Effects Of ACID REFLUX. DOWNEY, MICHAEL // Life Extension;Jun2015, p64 

    The article describes the approach called raft-forming alginate which can provide relief and protection from gastroesophageal reflux disease (GERD). Topics covered include the side effects of proton-pump inhibiting drugs, some of the conditions which can increase the likelihood of acid reflux or...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics